Publikationer

Sortér efter: Dato | Forfatter | Titel

Kesselring, A. M., Wit, F. W., Sabin, C. A., Lundgren, J. D., Gill, M. J., Gatell, J. M., Rauch, A., Montaner, J. S., de Wolf, F., Reiss, P., Mocroft, A. & Nevirapine Toxicity Multicohort Collaboration (Lars Østergaard, member) (2009). Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy. AIDS, 23(13), 1689-99. https://doi.org/10.1097/QAD.0b013e32832d3b54
Stensvold, C. R., Skov, J., Møller, L. N., Jensen, P. M., Kapel, C. M. O., Petersen, E. & Nielsen, H. V. (2009). Seroprevalence of human toxocariasis in Denmark. Clinical and Vaccine Immunology. https://doi.org/10.1128/CVI.00234-09
Duus, L. M., Christensen, A. V., Navntoft, D., Tarp, B., Nielsen, H. V. & Petersen, E. (2009). The schistosoma-specific antibody response after treatment in non-immune travellers. Scandinavian Journal of Infectious Diseases, 41(4), 285-90. https://doi.org/10.1080/00365540902756505
Comstedt, P., Storgaard, M. & Lassen, A. T. (2009). The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 17(1), 67. https://doi.org/10.1186/1757-7241-17-67
Silveira, C., Gargano, N., Kijlstra, A. & Petersen, E. (2009). Toxoplasma vaccines: appropriate end points and sample size in future human clinical trials. Expert Review of Anti-infective Therapy, 7(8), 905-8. https://doi.org/10.1586/eri.09.81